Cancer Caregiver Burden: Targeting Emotion Regulation in a Trial (ERT-ICs)
Primary Purpose
Anxiety Depression
Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Emotion Regulation Therapy
Sponsored by
About this trial
This is an interventional treatment trial for Anxiety Depression focused on measuring informal caregivers, caregiving, psychotherapy for caregivers, cancer, emotion regulation, distress, inflammation
Eligibility Criteria
Inclusion Criteria:
- Medium levels of distress (distress thermometer > 3) and at least moderate levels of worry or rumination
- Caregiver of patient with cancer
Exclusion Criteria:
- an expected survival of the patient of <6 months,
- active substance abuse (alcohol or drugs), and
- participation in other psychosocial trials.
Sites / Locations
- Unit for Psychooncology and Health Psychology
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Emotion Regulation Therapy
Usual Medical Care
Arm Description
8 sessions of Emotion Regulation Therapy.
No planned psychotherapy.
Outcomes
Primary Outcome Measures
Change in The Caregiver Reaction Assessment and EORTC-QLQ-30
Questionnaire measuring burden in ICs and quality of life cancer patients, respectively
Change in Hospital Anxiety and Depression Scale (HADS)
Questionnaire measuring anxiety and depression
Change in Penn State Worry Questionnaire
Questionnaire measuring worry
Change in Rumination Response Scale - Brooding subscale only
Questionnaire measuring brooding
Secondary Outcome Measures
Change in Difficulty in Emotion Regulation Scale
Questionnaire measuring emotion regulation
Change in Emotion Regulation Questionnaire
Questionnaire measuring emotion regulation
Change in Five Facet Mindfulness Questionnaire
Questionnaire measuring mindfulness
Change in Experiences Questionnaire
Questionnaire measuring psychological distancing
Change in The Pittsburgh Sleep Quality Index
Questionnaire measuring sleep quality
Change in quality of life - WHO-5
Questionnaire measuring quality of life
Change in Pro-inflammatory markers: CRP, TNFalpha, IL-1, IL-6
Serum-derived pro-inflammatory markers (only pre and post therapy)
Emotional closeness
2 items (actual and wanted emotional closeness) rated on a 0-10 scale
Emotional attention coping (EAC)
Questionnaire measuring emotion regulation
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02322905
Brief Title
Cancer Caregiver Burden: Targeting Emotion Regulation in a Trial
Acronym
ERT-ICs
Official Title
Cancer Caregiver Burden: Targeting Emotion Regulation in a Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
June 2018
Overall Recruitment Status
Completed
Study Start Date
August 2015 (Actual)
Primary Completion Date
June 25, 2018 (Actual)
Study Completion Date
December 31, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Aarhus
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Informal caregivers of cancer patients report high levels of psychological distress as evidenced in markedly increased levels of anxiety and depression. High levels of psychological distress in caregivers have also been found to be associated with poorer health and increased levels of pro-inflammatory cytokines that are well-established risk factors for physical illness and stress-related mortality. Previous psychological interventions using cognitive methods have only produced small effect sizes and more research on how to effectively alleviate caregiver burden is needed. The proposed project will investigate the effect of Emotion Regulation Therapy (ERT) for caregivers of cancer patients. ERT is a novel approach specifically targeting emotion regulation with the aim of improving mental and physical health. The effect of ERT will be examined in a randomized controlled trial comparing ERT to usual medical care (UMC).
Detailed Description
PURPOSE:
The primary purpose of the study is to test the efficacy of Emotion Regulation Therapy (ERT) for informal caregivers (ICs) of cancer patients. ERT is a manualized treatment for ICs and consists of 8 weekly sessions.
AIMS AND HYPOTHESES:
Intervention and mediation effects. In an RCT, the investigators will investigate the efficacy of an 8 session ERT for ICs on psychological and physical distress and a number of other health outcomes in both ICs and cancer patients. Outcomes in the ERT group will be compared to outcomes in a group of ICs and patients receiving usual medical care (UMC) (see Figure 1). ICs receiving ERT compared to ICs receiving UMC are expected to exhibit 1a) significant reductions in psychological distress and perceived caregiving burden, 1b) improvements in quality of life; and 1c) improvements in pro-inflammatory markers of stress/immune functioning. Likewise, patients whose ICs receive ERT are expected to report 2a) reduced anxiety and depression, 2b) improved quality of life and 2c) less chronic inflammation. Due to the design, these effects will be considered following the acute treatment period (pre, mid and post therapy). In addition to this, gains are expected to be maintained over the follow-up-period. In addition, 3) improvements are exptected to be maintained over the follow-up period. Finally, 4) improvements in adaptive emotion regulation (mindfulness, acceptance, and cognitive reappraisal) are expected to mediate the effect of ERT.
PARTICIPANTS AND PROCEDURES:
ICs of cancer patients with various cancer types will be consecutively recruited from Aarhus University Hospital, Denmark. Staff at the Outpatient Clinic at the Department of Oncology, Aarhus University Hospital, Denmark, will screen ICs at the department. Initially the investigators wanted to include caregivers of patients with lung and colorectal cancer only. However, in order to be able to include caregivers at a faster pace, it was decided - after one month during which only two caregivers were included - to broaden the patient group. Furthermore, it was decided that more than one IC per patient could participate.
After giving informed consent, participants will be randomized to Emotion Regulation Therapy (ERT) or usual medical care (UMC) in a ratio of 1:1 by means of computer-generated randomization lists. Outcome measures will be obtained pre-, mid-, and post-therapy as well as at 3 and 6-month follow-up. At every ERT session, ICs and clinicians will fill out a number of self-report the process measures. Cancer patients will be assessed pre- and post ERT, and at 3 and 6-months follow-up. Every IC and patient will provide blood samples before and after the intervention as well as at follow-ups.
Based on a power calculation (alpha=0.0125, beta=0.90), a dropout rate of 35%, and an intraclass correlation between ICs of the same patient of 0.20, the inclusion of 80 ICs will allow for an interaction effect between group (ERT vs. UMC) and time (acute treatment, thats is, pre, mid and post) of a medium effect size (d=0.5) to be significant.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anxiety Depression
Keywords
informal caregivers, caregiving, psychotherapy for caregivers, cancer, emotion regulation, distress, inflammation
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
80 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Emotion Regulation Therapy
Arm Type
Experimental
Arm Description
8 sessions of Emotion Regulation Therapy.
Arm Title
Usual Medical Care
Arm Type
No Intervention
Arm Description
No planned psychotherapy.
Intervention Type
Behavioral
Intervention Name(s)
Emotion Regulation Therapy
Intervention Description
8 sessions of ERT
Primary Outcome Measure Information:
Title
Change in The Caregiver Reaction Assessment and EORTC-QLQ-30
Description
Questionnaire measuring burden in ICs and quality of life cancer patients, respectively
Time Frame
Between-group effect at post, based on the whole treatment duration (pre-, mid- and post-therapy).
Title
Change in Hospital Anxiety and Depression Scale (HADS)
Description
Questionnaire measuring anxiety and depression
Time Frame
Between-group effect at post, based on the whole treatment duration (pre-, mid- and post-therapy).
Title
Change in Penn State Worry Questionnaire
Description
Questionnaire measuring worry
Time Frame
Between-group effect at post, based on the whole treatment duration (pre-, mid- and post-therapy).
Title
Change in Rumination Response Scale - Brooding subscale only
Description
Questionnaire measuring brooding
Time Frame
Between-group effect at post, based on the whole treatment duration (pre-, mid- and post-therapy).
Secondary Outcome Measure Information:
Title
Change in Difficulty in Emotion Regulation Scale
Description
Questionnaire measuring emotion regulation
Time Frame
Between-group effect at post, based on the whole treatment duration (pre-, mid- and post-therapy).
Title
Change in Emotion Regulation Questionnaire
Description
Questionnaire measuring emotion regulation
Time Frame
Between-group effect at post, based on the whole treatment duration (pre-, mid- and post-therapy).
Title
Change in Five Facet Mindfulness Questionnaire
Description
Questionnaire measuring mindfulness
Time Frame
Between-group effect at post, based on the whole treatment duration (pre-, mid- and post-therapy).
Title
Change in Experiences Questionnaire
Description
Questionnaire measuring psychological distancing
Time Frame
Between-group effect at post, based on the whole treatment duration (pre-, mid- and post-therapy).
Title
Change in The Pittsburgh Sleep Quality Index
Description
Questionnaire measuring sleep quality
Time Frame
Between-group effect at post, based on the whole treatment duration (pre-, mid- and post-therapy).
Title
Change in quality of life - WHO-5
Description
Questionnaire measuring quality of life
Time Frame
Between-group effect at post, based on the whole treatment duration (pre-, mid- and post-therapy).
Title
Change in Pro-inflammatory markers: CRP, TNFalpha, IL-1, IL-6
Description
Serum-derived pro-inflammatory markers (only pre and post therapy)
Time Frame
Between-group effect at post, based on the whole treatment duration (pre-, and post-therapy).
Title
Emotional closeness
Description
2 items (actual and wanted emotional closeness) rated on a 0-10 scale
Time Frame
Between-group effect at post, based on the whole treatment duration (pre-, mid- and post-therapy).
Title
Emotional attention coping (EAC)
Description
Questionnaire measuring emotion regulation
Time Frame
Between-group effect at post, based on the whole treatment duration (pre-, mid- and post-therapy).
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
69 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Medium levels of distress (distress thermometer > 3) and at least moderate levels of worry or rumination
Caregiver of patient with cancer
Exclusion Criteria:
an expected survival of the patient of <6 months,
active substance abuse (alcohol or drugs), and
participation in other psychosocial trials.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mia S O'Toole, MSc
Organizational Affiliation
University of Aarhus
Official's Role
Principal Investigator
Facility Information:
Facility Name
Unit for Psychooncology and Health Psychology
City
Aarhus C
ZIP/Postal Code
DK8000
Country
Denmark
12. IPD Sharing Statement
Citations:
PubMed Identifier
34047220
Citation
Mikkelsen MB, Elkjaer E, Mennin DS, Fresco DM, Zachariae R, Applebaum A, O'Toole MS. The impact of emotion regulation therapy on emotion differentiation in psychologically distressed caregivers of cancer patients. Anxiety Stress Coping. 2021 Jul;34(4):479-485. doi: 10.1080/10615806.2021.1929934. Epub 2021 May 28.
Results Reference
derived
Learn more about this trial
Cancer Caregiver Burden: Targeting Emotion Regulation in a Trial
We'll reach out to this number within 24 hrs